Listed

Neurogene Inc.

NGNENasdaqCIK 1404644HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$36.7m, Q2 FY2026
Net income−$34.5m, Q2 FY2026
Neurogene Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.9Revenue, Q2 FY2024, three months to 2024-06-30$925.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m11.6Research and development, Q3 FY2023, three months to 2023-09-30$11.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure12.2Research and development, Q4 FY2023, three months to 2023-12-31$12.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure13.5Research and development, Q1 FY2024, three months to 2024-03-31$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure15.7Research and development, Q2 FY2024, three months to 2024-06-30$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure16.3Research and development, Q3 FY2024, three months to 2024-09-30$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure15.3Research and development, Q4 FY2024, three months to 2024-12-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure17.8Research and development, Q1 FY2025, three months to 2025-03-31$17.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure19.4Research and development, Q2 FY2025, three months to 2025-06-30$19.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure17.2Research and development, Q3 FY2025, three months to 2025-09-30$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure20.6Research and development, Q4 FY2025, three months to 2025-12-31$20.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure25.2Research and development, Q1 FY2026, three months to 2026-03-31$25.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure25.5Research and development, Q2 FY2026, three months to 2026-06-30$25.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Operating income$m(15.2)Operating income, Q3 FY2023, three months to 2023-09-30−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure(14.7)Operating income, Q4 FY2023, three months to 2023-12-31−$14.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(18.8)Operating income, Q1 FY2024, three months to 2024-03-31−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure(20.1)Operating income, Q2 FY2024, three months to 2024-06-30−$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure(22.2)Operating income, Q3 FY2024, three months to 2024-09-30−$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(21.5)Operating income, Q4 FY2024, three months to 2024-12-31−$21.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(25.9)Operating income, Q1 FY2025, three months to 2025-03-31−$25.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(26.1)Operating income, Q2 FY2025, three months to 2025-06-30−$26.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(23.8)Operating income, Q3 FY2025, three months to 2025-09-30−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(27.5)Operating income, Q4 FY2025, three months to 2025-12-31−$27.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(33.3)Operating income, Q1 FY2026, three months to 2026-03-31−$33.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(36.7)Operating income, Q2 FY2026, three months to 2026-06-30−$36.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-18, accession 0001404644-24-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$3.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(14.6)Net income, Q3 FY2023, three months to 2023-09-30−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure2.4Net income, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(16.9)Net income, Q1 FY2024, three months to 2024-03-31−$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(18.5)Net income, Q2 FY2024, three months to 2024-06-30−$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(20.2)Net income, Q3 FY2024, three months to 2024-09-30−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(19.5)Net income, Q4 FY2024, three months to 2024-12-31−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(22.6)Net income, Q1 FY2025, three months to 2025-03-31−$22.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(22.0)Net income, Q2 FY2025, three months to 2025-06-30−$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(21.0)Net income, Q3 FY2025, three months to 2025-09-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure(24.7)Net income, Q4 FY2025, three months to 2025-12-31−$24.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(30.9)Net income, Q1 FY2026, three months to 2026-03-31−$30.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(34.5)Net income, Q2 FY2026, three months to 2026-06-30−$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Diluted EPS$ per share(32.67)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$32.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figurenot reported(1.00)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure(1.09)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure(1.19)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figurenot reported(1.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(1.05)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(0.99)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figurenot reported(1.39)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(1.53)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Basic EPS$ per share(32.67)Basic EPS, Q3 FY2023, three months to 2023-09-30−$32.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figurenot reported(1.00)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure(1.09)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure(1.19)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figurenot reported(1.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(1.05)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure(0.99)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figurenot reported(1.39)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(1.53)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure

Balance sheet

Cash and equivalents$112.5m, Q2 FY2026
Shareholders' equity$217.1m, Q2 FY2026
Neurogene Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m25.2Cash and equivalents, Q3 FY2023, at 2023-09-30$25.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure148Cash and equivalents, FY2023, at 2023-12-31$148.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0001404644-25-000012.Report this figure150Cash and equivalents, Q1 FY2024, at 2024-03-31$150.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure111Cash and equivalents, Q2 FY2024, at 2024-06-30$111.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure66.6Cash and equivalents, Q3 FY2024, at 2024-09-30$66.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure137Cash and equivalents, FY2024, at 2024-12-31$136.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure70.8Cash and equivalents, Q1 FY2025, at 2025-03-31$70.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure58.8Cash and equivalents, Q2 FY2025, at 2025-06-30$58.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure71.0Cash and equivalents, Q3 FY2025, at 2025-09-30$71.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure104Cash and equivalents, FY2025, at 2025-12-31$103.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure124Cash and equivalents, Q1 FY2026, at 2026-03-31$124.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure112Cash and equivalents, Q2 FY2026, at 2026-06-30$112.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Current assets$m79.9Current assets, Q3 FY2023, at 2023-09-30$79.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure200Current assets, FY2023, at 2023-12-31$200.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0001404644-25-000012.Report this figure174Current assets, Q1 FY2024, at 2024-03-31$174.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure159Current assets, Q2 FY2024, at 2024-06-30$159.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure144Current assets, Q3 FY2024, at 2024-09-30$143.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure316Current assets, FY2024, at 2024-12-31$315.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure296Current assets, Q1 FY2025, at 2025-03-31$296.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure279Current assets, Q2 FY2025, at 2025-06-30$279.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure271Current assets, Q3 FY2025, at 2025-09-30$270.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure272Current assets, FY2025, at 2025-12-31$271.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure247Current assets, Q1 FY2026, at 2026-03-31$246.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure229Current assets, Q2 FY2026, at 2026-06-30$228.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Total assets$m89.6Total assets, Q3 FY2023, at 2023-09-30$89.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure223Total assets, FY2023, at 2023-12-31$222.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0001404644-25-000012.Report this figure195Total assets, Q1 FY2024, at 2024-03-31$195.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure180Total assets, Q2 FY2024, at 2024-06-30$179.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure164Total assets, Q3 FY2024, at 2024-09-30$164.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure336Total assets, FY2024, at 2024-12-31$335.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure315Total assets, Q1 FY2025, at 2025-03-31$315.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure297Total assets, Q2 FY2025, at 2025-06-30$297.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure288Total assets, Q3 FY2025, at 2025-09-30$287.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure289Total assets, FY2025, at 2025-12-31$288.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure263Total assets, Q1 FY2026, at 2026-03-31$263.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure244Total assets, Q2 FY2026, at 2026-06-30$244.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Current liabilities$m5.2Current liabilities, Q3 FY2023, at 2023-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure23.0Current liabilities, FY2023, at 2023-12-31$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0001404644-25-000012.Report this figure11.8Current liabilities, Q1 FY2024, at 2024-03-31$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure13.1Current liabilities, Q2 FY2024, at 2024-06-30$13.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure15.8Current liabilities, Q3 FY2024, at 2024-09-30$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure15.2Current liabilities, FY2024, at 2024-12-31$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure14.1Current liabilities, Q1 FY2025, at 2025-03-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure15.4Current liabilities, Q2 FY2025, at 2025-06-30$15.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure14.7Current liabilities, Q3 FY2025, at 2025-09-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure16.4Current liabilities, FY2025, at 2025-12-31$16.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure18.9Current liabilities, Q1 FY2026, at 2026-03-31$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure21.5Current liabilities, Q2 FY2026, at 2026-06-30$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Total liabilities$m14.4Total liabilities, Q3 FY2023, at 2023-09-30$14.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure36.5Total liabilities, FY2023, at 2023-12-31$36.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0001404644-25-000012.Report this figure24.6Total liabilities, Q1 FY2024, at 2024-03-31$24.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001404644-24-000057.Report this figure24.8Total liabilities, Q2 FY2024, at 2024-06-30$24.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure26.7Total liabilities, Q3 FY2024, at 2024-09-30$26.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure25.4Total liabilities, FY2024, at 2024-12-31$25.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure23.5Total liabilities, Q1 FY2025, at 2025-03-31$23.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure24.1Total liabilities, Q2 FY2025, at 2025-06-30$24.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure22.3Total liabilities, Q3 FY2025, at 2025-09-30$22.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure23.7Total liabilities, FY2025, at 2025-12-31$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure25.4Total liabilities, Q1 FY2026, at 2026-03-31$25.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure27.2Total liabilities, Q2 FY2026, at 2026-06-30$27.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure
Shareholders' equity$m(183)Shareholders' equity, Q3 FY2023, at 2023-09-30−$183.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure186Shareholders' equity, FY2023, at 2023-12-31$186.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001404644-26-000019.Report this figure171Shareholders' equity, Q1 FY2024, at 2024-03-31$170.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure155Shareholders' equity, Q2 FY2024, at 2024-06-30$155.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure137Shareholders' equity, Q3 FY2024, at 2024-09-30$137.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure310Shareholders' equity, FY2024, at 2024-12-31$310.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure292Shareholders' equity, Q1 FY2025, at 2025-03-31$291.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure273Shareholders' equity, Q2 FY2025, at 2025-06-30$273.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure266Shareholders' equity, Q3 FY2025, at 2025-09-30$265.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure265Shareholders' equity, FY2025, at 2025-12-31$264.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure238Shareholders' equity, Q1 FY2026, at 2026-03-31$237.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure217Shareholders' equity, Q2 FY2026, at 2026-06-30$217.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure

Cash flow

Operating cash flow−$23.8m, Q2 FY2026
Capital expenditure$354.0k, Q2 FY2026
Neurogene Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-18, accession 0001404644-24-000104. Derived: 9-month figure less the 6-month figure.Report this figure(17.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure(15.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001404644-25-000081. Derived: 6-month figure less the 3-month figure.Report this figure(15.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001404644-25-000101. Derived: 9-month figure less the 6-month figure.Report this figure(17.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$17.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(20.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(19.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001404644-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure(19.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001404644-25-000101. Derived: 9-month figure less the 6-month figure.Report this figure(17.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(26.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure(23.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001404644-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-18, accession 0001404644-24-000104. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$128.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0001404644-25-000012. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$65.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$460.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001404644-25-000081. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$167.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001404644-25-000101. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$116.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$780.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$148.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001404644-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$127.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001404644-25-000101. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$128.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001404644-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$281.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$354.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001404644-26-000059. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)22.55m, Q2 FY2026
Neurogene Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares11.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3011,050,207 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001628280-23-038797.Report this figure55.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3155,420,912 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-08, accession 0001628280-23-016425.Report this figure0.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30444,465 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001404644-24-000086.Report this figure0.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30446,255 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-18, accession 0001404644-24-000104.Report this figure16.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3116,903,735 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001404644-25-000041.Report this figure16.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3016,941,524 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001404644-25-000081.Report this figure17.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3016,953,443 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure21.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3120,996,287 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure21.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3021,055,378 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure21.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3021,168,431 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001404644-25-000101.Report this figure22.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3122,305,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001404644-26-000037.Report this figure22.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3022,552,032 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure

Shares outstanding: 20.01mShares outstanding, period not labelled, at 2026-08-0720,011,382 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001404644-26-000059.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.